Clinical Trials Directory

Trials / Conditions / Head and Neck Carcinoma

Head and Neck Carcinoma

80 registered clinical trials studyying Head and Neck Carcinoma23 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingA New Way to Share Radiation Therapy Plans Between Doctors, CORRECT Trial
NCT07282444
Wake Forest University Health SciencesN/A
RecruitingThe Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and
NCT07285044
Mayo ClinicPhase 2
RecruitingTongue-out Radiation Therapy (TORT) for the Mitigation of Radiotherapy-related Toxicities in Patients With Hea
NCT07227792
Yvonne MoweryN/A
RecruitingA Financial Intervention (Financial Compass) to Identify and Address Financial Hardship Among Head and Neck Ca
NCT06896695
Roswell Park Cancer InstituteN/A
RecruitingDetermining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematolog
NCT07118176
Jonsson Comprehensive Cancer CenterPhase 1
RecruitingVirtual Reality Interventions for the Improvement of Depression, Anxiety and Pain in Patients With Head and Ne
NCT06985784
City of Hope Medical CenterN/A
RecruitingAccelerator-based BNCT (Boron Neutron Capture Therapy) for Head and Neck Carcinoma.
NCT07058116
Neutron Therapeutics, LLCPhase 1
RecruitingAntibiotic Treatment Effects on Intratumoral Bacteria Modulation in Surgical Patients With Oral Cancer
NCT06627270
Case Comprehensive Cancer CenterPhase 2
RecruitingHeavy Strength Training in Head and Neck Cancer Survivors
NCT06289049
University of AlbertaPhase 2
RecruitingPersonalized Ultrafractionated Stereotactic Adaptive Radiotherapy for Palliative Head and Neck Cancer Treatmen
NCT06572423
Jonsson Comprehensive Cancer CenterN/A
WithdrawnDefining Musical Toxicity and Its Effect on Patient Well-being
NCT06494046
Mayo Clinic
RecruitingAn Integrative Multi-Omic Characterization of Head and Neck Carcinogenesis, Progression and Recurrence
NCT06420219
University of Southern California
CompletedOptimization of Communication Between Surgery and Pathology
NCT07378345
Heidelberg UniversityN/A
CompletedAn Exercise Prehabilitation Intervention for Improving Mobility and Recovery Outcomes in Patients Undergoing H
NCT06079697
OHSU Knight Cancer InstituteN/A
WithdrawnStrataXRT for the Prevention and Treatment of Radiation Dermatitis in Breast Cancer or Head and Neck Cancer Pa
NCT05073172
OHSU Knight Cancer InstituteN/A
RecruitingEvaluation of Radiobiological Effects in Skin Toxicities Head and Neck Cancer Patients With PBS Proton Therapy
NCT06183268
Covenant Health Cancer CenterN/A
RecruitingRepeatability and Reproducibility of the ADC Map in Head and Neck Cancer. Prospective Multicenter Study
NCT06749301
Regina Elena Cancer Institute
RecruitingTherapeutic Vaccine in Patients With Human Papillomavirus HPV-positive Oropharyngeal Cancer
NCT06007092
Gustave Roussy, Cancer Campus, Grand ParisPhase 1 / Phase 2
CompletedThe SHINE-MDT Randomized Controlled Trial
NCT05828004
West China HospitalN/A
RecruitingDosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head an
NCT05526924
University of ChicagoPhase 1
WithdrawnA Pneumatic Compression Device for the Treatment of Lymphedema in Patients With Stage II-IV Head and Neck Canc
NCT05512767
Mayo ClinicN/A
RecruitingA Study of Decreasing Radiation Therapy and Chemotherapy in People With Head and Neck Cancer
NCT05544136
Memorial Sloan Kettering Cancer CenterPhase 2
RecruitingCollecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
NCT05334069
Alliance for Clinical Trials in Oncology
RecruitingAIOCC Italian Registry on Head and Neck Carcinomas
NCT06248944
Italian Head&Neck Society
Active Not RecruitingPredicting Radiological Extranodal Extension in Oropharyngeal Carcinoma Patients Using AI
NCT05565313
Maastricht Radiation Oncology
CompletedEvaluating Patient Reported Outcomes in Radiation Therapy, the PRO-RT Study
NCT05224271
Mayo Clinic
Active Not RecruitingIntensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT
NCT05075980
Mayo ClinicPhase 2
CompletedRemote Monitoring in Cancer Care: A Platform Study
NCT05018208
Mayo Clinic
TerminatedMilademetan in Advanced/Metastatic Solid Tumors
NCT05012397
Rain Oncology IncPhase 2
Active Not RecruitingInterdisciplinary Interventions to Address Pain Management Among Head and Neck Cancer Patients
NCT05077072
M.D. Anderson Cancer CenterPhase 2
CompletedA Digital Intervention Protocol to Enhance Recovery After Head and Neck Surgery
NCT04814524
OHSU Knight Cancer InstituteN/A
RecruitingCustomized 3D Printed Oral Stents During Head and Neck Radiotherapy
NCT04870762
M.D. Anderson Cancer CenterPhase 2
UnknownPost-Operative Radiotherapy De-Escalation of Negative Nodal Regions in Head and Neck Squamous Cell Carcinoma
NCT05650034
National Cancer Institute, EgyptN/A
CompletedExercise Training and Behavioral Modification for the Improvement of Physical Activity in Head and Neck Cancer
NCT04788264
Thomas Jefferson UniversityN/A
Active Not RecruitingDyadic Yoga Intervention for the Improvement of Healthcare Utilization and Quality of Life in Patients With He
NCT04890834
M.D. Anderson Cancer CenterN/A
TerminatedCollection of Clinical Data and Specimens for Research on Head and Neck and Communication Disorders
NCT04618432
National Institute on Deafness and Other Communication Disorders (NIDCD)
Active Not RecruitingPersonal Health Train for Radiation Oncology in India and The Netherlands
NCT04655469
Maastricht Radiation Oncology
CompletedTadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer
NCT03993353
University of California, San DiegoPhase 2
CompletedIPI-549 in Patients With Locally Advanced HPV+ and HPV- Head and Neck Squamous Cell Carcinoma
NCT03795610
Assuntina G. Sacco, MDPhase 2
CompletedEffects of Human Papillomavirus Diagnosis on Relationships of Patients With Head and Neck Cancer
NCT04666428
Thomas Jefferson University
RecruitingCancer Genetic Testing in Ethnic Populations
NCT04475640
Mayo ClinicN/A
RecruitingOropharynx (OPX) Biomarker Trial
NCT06356272
Mayo Clinic
Active Not RecruitingExperimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal a
NCT04147494
Jonsson Comprehensive Cancer CenterEARLY_Phase 1
Active Not RecruitingHigh Dose Steroid Therapy (Prednisone or Methylprednisolone) for the Improvement of Symptoms of Late Radiation
NCT04151082
M.D. Anderson Cancer CenterPhase 1 / Phase 2
TerminatedPhotoacoustic Imaging for Measuring Tumors and Normal Tissue in Patients With Head and Neck Cancer
NCT04110249
Roswell Park Cancer InstituteN/A
CompletedPain Management for Head and Neck Cancer Survivors
NCT05115825
OHSU Knight Cancer InstituteN/A
CompletedGeriatric and Quality of Life Assessments in Older Patients With Non-metastatic or Metastatic Head and Neck or
NCT03902535
City of Hope Medical Center
TerminatedStudy Evaluating The Role of ClO2 on Mucositis for Pt. Undergoing Head/Neck Radiotherapy
NCT03602066
University of ArizonaPhase 2
Active Not RecruitingClinical Data Collection in Studying Clinical Factors Associated With Post-Surgery Chronic Opioid Use in Patie
NCT03888651
M.D. Anderson Cancer Center
WithdrawnNear-Infrared Image Guided Surgical Resection With Indocyanine Green in Treating Patients With Head and Neck C
NCT03745690
Jonsson Comprehensive Cancer CenterPhase 1 / Phase 2
CompletedFALCOn (Facteur AnthropoLogique Cancer Orl)
NCT03663985
Institut Claudius Regaud
Active Not RecruitingManual Therapy in Treating Fibrosis-Related Late Effect Dysphagia in Head and Neck Cancer Survivors
NCT03612531
M.D. Anderson Cancer CenterN/A
CompletedEffects of Avmacol® in the Oral Mucosa of Patients Following Curative Treatment for Tobacco-related Head and N
NCT03268993
University of PittsburghN/A
CompletedStudy of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Ge
NCT03602079
Klus Pharma Inc.Phase 1 / Phase 2
UnknownA Study of Anlotinib in Recurrent/Metastatic Head and Neck Adenocarcinomas
NCT03591666
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong UniversityPhase 2
RecruitingVMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or
NCT03556228
VM Oncology, LLCPhase 1 / Phase 2
CompletedTesting Lenvatinib and Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma and Cutaneous
NCT03524326
Memorial Sloan Kettering Cancer CenterPhase 1
CompletedRemote Activity Monitored by Fitbit Charge 3 in Investigating Daily Step and Sleep Data in Participants With H
NCT03489252
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityN/A
CompletedCetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma
NCT03370276
H. Lee Moffitt Cancer Center and Research InstitutePhase 1 / Phase 2
WithdrawnNestle Impact Advanced Recovery in Improving Surgery Recovery in Patients With Head and Neck Cancer
NCT03261180
OHSU Knight Cancer InstituteN/A
CompletedHealth Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer
NCT03154190
Stanford UniversityN/A
CompletedProvider Training in Increasing Patient Tobacco Cessation Counseling and Referrals for Patients With Cancer Un
NCT03135782
OHSU Knight Cancer InstituteN/A
CompletedLow-Carbohydrate Normocaloric Diet in Patients With Head and Neck Carcinoma (HNC)
NCT02555176
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityN/A
CompletedNurse-Driven Telephone Intervention in Improving Side Effects in Cancer Patients Undergoing Chemotherapy
NCT03964896
M.D. Anderson Cancer CenterN/A
CompletedUse of a Non-ICU Specialty Ward For Immediate Post-operative Management of Head and Neck Free Flaps
NCT03340038
University of California, DavisN/A
CompletedPembrolizumab Plus Docetaxel for the Treatment of Recurrent or Metastatic Head and Neck Cancer
NCT02718820
Medical University of ViennaPhase 1 / Phase 2
CompletedA Study to Assess the Safety, Tolerability and Anti-tumour Activity of Ascending Doses of Selumetinib in Combi
NCT02586987
AstraZenecaPhase 1
Active Not RecruitingBioelectrical Impedance Analysis in Estimating Body Composition in Patients With Stage I-IV Head and Neck Canc
NCT02615275
M.D. Anderson Cancer CenterN/A
Active Not RecruitingTargeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymph
NCT02465060
National Cancer Institute (NCI)Phase 2
Active Not RecruitingRe-irradiation of Recurrent Head and Neck Cancer
NCT01973179
Technische Universität Dresden
CompletedContinuous Activity Monitoring During Fractionated Radiotherapy in Patients With Head and Neck, Lung, or Gastr
NCT02649569
Montefiore Medical Center
CompletedModified Dakin's Solution in Reducing Radiation-Induced Dermatitis in Patients With Head and Neck Cancer Under
NCT02369835
Stanford UniversityPhase 3
CompletedAcupuncture-Like Transcutaneous Electrical Nerve Stimulation in Treating Radiation-Induced Xerostomia in Patie
NCT02474095
Roswell Park Cancer InstituteN/A
CompletedPhase I Study of Lurbinectedin (PM01183) in Combination With Paclitaxel, With or Without Bevacizumab, in Selec
NCT01831089
PharmaMarPhase 1
Active Not RecruitingNeurofeedback in Decreasing Acute Radiotherapy-Induced Pain in Patients With Head and Neck Cancer
NCT02543320
M.D. Anderson Cancer CenterN/A
TerminatedIAEA-HypoX. Accelerated Radiotherapy With or Without Nimorazole in Squamous Cell Carcinoma of the Head and Nec
NCT01507467
Danish Head and Neck Cancer GroupPhase 3
Active Not RecruitingMedical Data Collection of Patients With Head and Neck Cancer Treated With Proton Therapy
NCT01627093
M.D. Anderson Cancer Center
CompletedFeasibility of VMAT and CBCT for Head and Neck Carcinomas
NCT01384890
British Columbia Cancer AgencyPhase 1
CompletedTrial of OTD70DERM® in Radio-dermatitis Induced by Radiotherapy-Erbitux®
NCT01228565
Groupe Oncologie Radiotherapie Tete et CouPhase 3
RecruitingData Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy
NCT00991094
M.D. Anderson Cancer Center